Wolfe Research Starts ResMed (RMD) at Outperform

April 5, 2022 4:15 PM EDT
Get Alerts RMD Hot Sheet
Price: $222.05 -1.14%

Rating Summary:
    12 Buy, 10 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 10 | Down: 31 | New: 13
Join SI Premium – FREE

Wolfe Research analyst Mike Polark initiates coverage on ResMed (NYSE: RMD) with a Outperform rating and a price target of $280.00.

For an analyst ratings summary and ratings history on ResMed click here. For more ratings news on ResMed click here.

Shares of ResMed closed at $245.71 yesterday.

You May Also Be Interested In

Related Categories

New Coverage